InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-11.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Powell Andrew Kenneth William, 董事. Insider active across 2 companies, notably Landec CORP \ca\. In total, 8 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 1 June 2021. The latest transaction was filed on 1 March 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Powell Andrew Kenneth William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
4,660 股Common StockSEC:0001415889-24-015368:0
8,500 股@ US$1.23100.0% 占其流量Common StockSEC:0001209191-24-004385:0
标准退出：2024年5月30日 (T+90)
4,507 股Common StockSEC:0001209191-23-034399:0
4,000 股0Common StockSEC:0001209191-23-004300:0
7,059 股@ US$9.5028.3% 占其流量Common StockSEC:0001628280-22-016491:0
709 股0Common StockSEC:0001209191-22-034601:0
5,500 股0Common StockSEC:0001209191-21-067863:0
8,303 股@ US$11.6455.9% 占其流量Common StockSEC:0001593968-21-001521:0
8 条申报中的 8 条
About Powell Andrew Kenneth William
Andrew Kenneth William Powell is a Director at LANDEC CORP \CA\ and Aclaris Therapeutics, Inc. In this role, he contributes to the governance of the companies and strategic decision-making. Powell brings his expertise to support the missions of these firms.
